Understanding skeletal muscle wasting in critically ill patients

被引:9
|
作者
Lodeserto, Frank [1 ]
Yende, Sachin [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA 15261 USA
来源
CRITICAL CARE | 2014年 / 18卷 / 06期
关键词
CRITICAL ILLNESS; PROTEIN-SYNTHESIS; MYOPATHY;
D O I
10.1186/s13054-014-0617-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Survivors of critical illness demonstrate skeletal muscle wasting with associated functional impairment. Methods Objective: The objective was to perform a comprehensive prospective characterization of skeletal muscle wasting, defining the pathogenic roles of altered protein synthesis and breakdown. Design: Prospective observational study. Setting: Patients were recruited from a university and community hospital in England. Subjects: The study involved 63 critically ill patients > 18 years old who were anticipated to be intubated > 48 hours and to spend > 7 days in the ICU and to survive their ICU stay. Subjects were enrolled within 24 hours of admission. Outcomes: Muscle loss was determined through serial ultrasound measurement of the rectus femoris cross-sectional area (CSA) on days 1, 3, 7, and 10. In a subset of patients, the fiber CSA area was quantified along with the ratio of protein to DNA on days 1 and 7. Histopathological analysis was performed. In addition, muscle protein synthesis, breakdown rates, and respective signaling pathways were characterized. Results There were significant reductions in the rectus femoris CSA observed at day 10 (-17.7%; 95% confidence interval (CI), -25.9 to 8.1%; P < 0.001). In the 28 patients assessed by all three measurement methods on days 1 and 7, the rectus femoris CSA decreased by 10.3% (95% CI, 6.1 to 14.5%), the fiber CSA by 17.5% (95% CI, 5.8 to 29.3%), and the ratio of protein to DNA by 29.5% (95% CI, 13.4 to 45.6%). Decrease in the rectus femoris CSA was greater in patients who experienced multiorgan failure by day 7 (-15.7%; 95% CI, -27.7 to 11.4%) compared with single organ failure (-3.0%; 95% CI, -5.3 to 2.1%; P < 0.001), even by day 3 (-8.7%; 95% CI, -59.3 to 50.6% versus -1.8%; 95% CI, -12.3 to 10.5%, respectively; P = 0.03). Myofiber necrosis occurred in 20 of 37 patients (54.1%). Protein synthesis measured by the muscle protein fractional synthetic rate was depressed in patients on day 1 (0.035%/hour; 95% CI, 0.023 to 0.047%/hour) compared with rates observed in fasted healthy controls (0.039%/hour; 95% CI, 0.029 to 0.048%/hour; P = 0.57) and increased by day 7 (0.076%; 95% CI, 0.032 to 0.120%/hour; P = 0.03) to rates associated with fed controls (0.065%/hour; 95% CI, 0.049 to 0.080%/hour; P = 0.30), independent of nutritional load. Leg protein breakdown remained elevated throughout the study (8.5; 95% CI, 4.7 to 12.3 mu mol phenylalanine/minute/ideal body weight x 100 to 10.6; 95% CI, 6.8 to 14.4 mu mol phenylalanine/minute/ideal body weight x 100; P = 0.40). The pattern of intracellular signaling supported increased breakdown (n = 9, r = -0.83, P = 0.005) and decreased synthesis (n = 9, r = -0.69, P = 0.04). Conclusions Among these critically ill patients, muscle wasting occurred early and rapidly during the first week of critical illness and was more severe among those with multiorgan failure compared with single organ failure. These findings may provide insights into skeletal muscle wasting and critical illness.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Understanding skeletal muscle wasting in critically ill patients
    Frank Lodeserto
    Sachin Yende
    [J]. Critical Care, 18
  • [2] Acute Muscle Wasting Among Critically Ill Patients
    Heyland, Daren
    Earthman, Carrie
    Compher, Charlene
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (06): : 621 - 622
  • [3] Skeletal muscle strength in critically ill patients
    ML Harris
    C-H Hamnegard
    MI Polkey
    J Moxham
    [J]. Critical Care, 3 (Suppl 1):
  • [4] Association of nutritional delivery on skeletal muscle wasting and inflammation in critically ill adult patients: a systematic review
    Liang, Kaifeng
    Puthucheary, Zudin
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2021, 80 (OCE1)
  • [5] Muscular weakness and muscle wasting in the critically ill
    Schefold, Joerg C.
    Wollersheim, Tobias
    Grunow, Julius J.
    Luedi, Markus M.
    Z'Graggen, Werner J.
    Weber-Carstens, Steffen
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2020, 11 (06) : 1399 - 1412
  • [6] Skeletal muscle glutathione is depleted in critically ill patients
    Hammarqvist, F
    Luo, JL
    Cotgreave, IA
    Andersson, K
    Wernerman, J
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (01) : 78 - 84
  • [7] Ultrasonographic Features of Muscular Weakness and Muscle Wasting in Critically Ill Patients
    Umbrello, Michele
    Brogi, Etrusca
    Formenti, Paolo
    Corradi, Francesco
    Forfori, Francesco
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [8] Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review
    Nicola A Maffiuletti
    Marc Roig
    Eleftherios Karatzanos
    Serafim Nanas
    [J]. BMC Medicine, 11
  • [9] Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review
    Maffiuletti, Nicola A.
    Roig, Marc
    Karatzanos, Eleftherios
    Nanas, Serafim
    [J]. BMC MEDICINE, 2013, 11
  • [10] Effect of passive stretching on the wasting of muscle in the critically ill
    Griffiths, RD
    Palmer, TEA
    Helliwell, T
    MacLennan, P
    MacMillan, RR
    [J]. NUTRITION, 1995, 11 (05) : 428 - 432